On March 25-27, project partners of MEDAIGENCY came together in Naples, Italy, for the project’s First Steering Committee Meeting, marking an important milestone in moving from planning to implementation.
Hosted by project partners at So.Re.Sa. S.p.A. – Società Regionale per la Sanità and Latitiudo40, the meeting brought together representatives from Lebanon, Palestine, Türkiye, Italy, and Spain to review project progress, strengthen coordination, and align next steps for the development of AI-powered solutions that support emergency preparedness, response, and recovery.
Beyond project management discussions, the Naples meeting served as an opportunity to bring together the boards that will help guide MEDAIGENCY throughout its implementation. The event featured the first meeting of the Ethics Advisory Board (EAB), bringing together international experts in ethics, artificial intelligence, public health, and governance. The EAB will play an important role in ensuring that the solutions developed under MEDAIGENCY are responsible, transparent, inclusive, and aligned with ethical standards.
As MEDAIGENCY works to develop and adapt AI-powered tools for use in emergency health systems, ethics remains central to the project approach. Through the Ethics Advisory Board, the project aims to ensure that issues such as privacy, bias, fairness, accountability, and human oversight are considered from the earliest stages of development to obtain “ethics-by-design” solutions.
The Naples meeting also hosted the first Stakeholders Board Meeting, bringing together policymakers, health actors, emergency responders, civil society representatives, academics, and other relevant institutions from across participating countries.
The Stakeholders Board serves as a platform for dialogue and co-creation, helping ensure that the solutions developed under MEDAIGENCY respond to real needs and can be effectively adopted within national systems and local contexts. Stakeholders will continue to be engaged throughout the project through regular consultations, feedback sessions, validation exercises, and participation in project activities.
Together, these meetings reflected one of MEDAIGENCY’s core principles: meaningful innovation requires more than technology alone. It requires collaboration and the active involvement of the people and institutions that will ultimately use, support, and benefit from these solutions.
Over the coming months, MEDAIGENCY partners will continue advancing the technology development, stakeholder engagement, and ethics-by-design processes that will shape the project’s AI-powered solutions.
Next Med
